Investec Asset Management LTD cut its stake in shares of CME Group Inc. (NASDAQ:CME) by 1.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,489,351 shares of the company’s stock after selling 30,421 shares during the period. CME Group accounts for approximately 1.5% of Investec Asset Management LTD’s portfolio, making the stock its 12th largest position. Investec Asset Management LTD owned approximately 0.74% of CME Group worth $287,147,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in CME. Johnson Financial Group Inc. raised its stake in shares of CME Group by 5.9% in the fourth quarter. Johnson Financial Group Inc. now owns 899 shares of the company’s stock valued at $104,000 after buying an additional 50 shares during the period. Bronfman E.L. Rothschild L.P. raised its stake in shares of CME Group by 4.0% in the third quarter. Bronfman E.L. Rothschild L.P. now owns 1,155 shares of the company’s stock valued at $121,000 after buying an additional 44 shares during the period. Advisors Preferred LLC bought a new stake in shares of CME Group during the third quarter valued at about $180,000. Warren Averett Asset Management LLC bought a new stake in shares of CME Group during the third quarter valued at about $211,000. Finally, Trustco Bank Corp N Y bought a new stake in shares of CME Group during the third quarter valued at about $214,000. 80.06% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Inc. (NASDAQ:CME) traded up 0.06% during midday trading on Friday, reaching $121.90. 215,556 shares of the company traded hands. The company has a market capitalization of $41.21 billion, a price-to-earnings ratio of 26.91 and a beta of 0.88. The stock’s 50 day moving average is $118.21 and its 200 day moving average is $111.30. CME Group Inc. has a one year low of $89.00 and a one year high of $124.01.
This article was originally published by and is the sole property of Zolmax. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://zolmax.com/investing/cme-group-inc-cme-position-cut-by-investec-asset-management-ltd/1208341.html
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, February 2nd. The company reported $1.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.03. CME Group had a net margin of 42.67% and a return on equity of 7.28%. The firm had revenue of $913 million for the quarter, compared to the consensus estimate of $881.46 million. During the same period in the prior year, the firm posted $0.92 earnings per share. The company’s revenue for the quarter was up 12.2% on a year-over-year basis. On average, equities analysts anticipate that CME Group Inc. will post $4.81 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, March 27th. Stockholders of record on Friday, March 10th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.17%. This is an increase from CME Group’s previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Wednesday, March 8th. CME Group’s dividend payout ratio is presently 52.98%.
“CME Group Inc. (CME) Position Cut by Investec Asset Management LTD” was originally posted by Zolmax and is the property of of Zolmax. If you are viewing this report on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The original version of this report can be read at https://zolmax.com/investing/cme-group-inc-cme-position-cut-by-investec-asset-management-ltd/1208341.html.
Several equities research analysts recently issued reports on the stock. Zacks Investment Research lowered shares of CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, February 8th. J P Morgan Chase & Co lowered shares of CME Group from an “overweight” rating to a “neutral” rating in a report on Tuesday, January 31st. RBC Capital Markets set a $92.00 price target on shares of CME Group and gave the company a “sell” rating in a report on Friday, October 28th. Finally, Royal Bank Of Canada decreased their price target on shares of CME Group from $97.00 to $92.00 and set an “underperform” rating on the stock in a report on Friday, October 28th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $103.96.
In other news, CEO Terrence A. Duffy sold 17,375 shares of the stock in a transaction dated Friday, November 25th. The shares were sold at an average price of $112.58, for a total value of $1,956,077.50. Following the sale, the chief executive officer now directly owns 127,739 shares of the company’s stock, valued at $14,380,856.62. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, President Bryan T. Durkin sold 15,000 shares of the stock in a transaction dated Wednesday, November 30th. The stock was sold at an average price of $112.85, for a total transaction of $1,692,750.00. Following the completion of the sale, the president now directly owns 68,680 shares in the company, valued at $7,750,538. The disclosure for this sale can be found here. Over the last three months, insiders sold 98,819 shares of company stock worth $11,554,661. Insiders own 0.61% of the company’s stock.
CME Group Company Profile
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.